Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study to Evaluate the Efficacy and Safety Imidafenacin Versus Fesoterodine in Patients With Overactive Bladder

NCT01578304 is registered in ClinicalTrials.gov with LG Life Sciences as lead sponsor.

NCT NCT01578304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01578304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study to Evaluate the Efficacy and Safety Imidafenacin Versus Fesoterodine in Patients With Overactive Bladder
Lead sponsor
LG Life Sciences
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2010
Completion date
October 31, 2011
Enrollment
207 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder